AVE Science & Technology Co 688067.SS · CNY

Its shares trade on Shanghai under the ticker 688067.SS. It has been listed since 16 June 2021. In the fiscal year to 31 December 2025, it reported revenue of CN¥230.0m and net income of CN¥28.9m. At that date it held total assets of CN¥580.1m and shareholders' equity of CN¥514.4m.

AVE Science & Technology Co., Ltd. engages in the research, development, production, sale, and service of clinical testing and analysis instruments. The company is headquartered in Changsha, Hunan. The company went IPO on 2021-06-16. The Company’s main products include urine formed component analyzer, urine dry chemistry analyzer, urine full item automatic analyzer, automatic stool analyzer, automatic body fluid analyzer, reproductive tract secretion analyzer, and special supporting in vitro diagnostic reagents and medical consumables and other products. The firm's products are mainly used in inspection departments of various medical and health institutions. The firm distributes its products both in the domestic market and to overseas markets.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Jianwen DingChairman of the Board, General Manager, since 2012CN¥418,200
• Mr. Kunxiang LongChief Financial OfficerCN¥269,700
• Mr. Changqing LinDeputy General Manager, Acting Secretary of the Board, Director, since 2012CN¥417,600
• Mr. Fengliang ZhouDeputy General Manager, Director, since 2012CN¥355,200
• Ms. Ting DingDirector
• Ms. Ping WanIndependent Director
• Mr. Xianyou WangIndependent DirectorCN¥60,000
• Mr. Ying ZhangIndependent Director

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.